atenolol has been researched along with methysergide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, K; Ishikawa, T; Kimura, S; Masaki, T; Yanagisawa, M | 1 |
| Dalton, DW | 1 |
| Mulleners, WM; Steiner, TJ; Whitmarsh, TE | 1 |
| Henry, P | 1 |
4 other study(ies) available for atenolol and methysergide
| Article | Year |
|---|---|
Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Animals; Atenolol; Atrial Function; Calcium; Cimetidine; Diphenhydramine; Endothelins; Guinea Pigs; Heart Atria; In Vitro Techniques; Isoproterenol; Male; Methysergide; Myocardial Contraction; Nicardipine; Peptides; Potassium; Quinazolines; Reference Values | 1988 |
The cardiovascular effects of centrally administered 5-hydroxytryptamine in the conscious normotensive and hypertensive rat.
Topics: Animals; Atenolol; Atropine Derivatives; Blood Pressure; Bradycardia; Drug Interactions; Heart; Heart Rate; Hypertension; Injections, Intravenous; Male; Methysergide; Rats; Serotonin; Serotonin Antagonists | 1986 |
Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better.
Topics: Administration, Oral; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Atenolol; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Female; Humans; Male; Methysergide; Middle Aged; Migraine Disorders; Pizotyline; Propranolol; Sympatholytics; Treatment Refusal; Vasoconstrictor Agents; Vasodilator Agents | 1998 |
[Migraine: a disease, not a symptom].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Atenolol; Diagnosis, Differential; Dihydroergotamine; Flunarizine; GABA Agents; Humans; Indoramin; Methysergide; Migraine Disorders; Oxazolidinones; Serotonin Antagonists; Serotonin Receptor Agonists; Tryptamines; Valproic Acid; Vasoconstrictor Agents; Vasodilator Agents | 2002 |